Physician profile
Andrew J Kaplan
NPI 1154399343
$203,509.24
in general payments reported to CMS, 2019-2025
45 companies · $9,850 in 2025
The $9,850 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $13K · 2022: $19K · 2023: $79K · 2024: $58K · 2025: $9,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $64K · Honoraria: $56K · Food and Beverage: $14K · Travel and Lodging: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,419.80 |
| Honoraria | $56,200.00 |
| Food and Beverage | $14,074.45 |
| Travel and Lodging | $11,810.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $116,624.00 | 2019-2025 | Optimizer, Optimizer |
| Avertix Medical, INC | $61,419.80 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $3,865.37 | 2019-2024 | Eliquis, Camzyos |
| Biosense Webster, INC. | $3,663.74 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3,313.14 | 2019-2025 | Lifevest |
| Pfizer INC. | $2,891.56 | 2019-2024 | |
| Boston Scientific Corporation | $2,399.82 | 2019-2025 | General - Therapies, General - Brady, General - Tachy |
| Haemonetics Corporation | $2,250.00 | 2024 | |
| Medtronic, INC. | $1,431.24 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Corevalve Evolut R |
| Abbott Laboratories | $804.13 | 2019-2025 | Cardiomems, Perclose Prostyle |
| Acutus Medical, INC. | $772.13 | 2021 | |
| Merck Sharp & Dohme LLC | $590.35 | 2021-2025 | Verquvo, Capvaxive |
| Kestra Medical Technology Services, INC. | $504.21 | 2022-2025 | Assure Wcd |
| Cardiva Medical, INC. | $378.44 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Ensoetm |
| Cvrx, INC. | $358.96 | 2024-2025 | Barostim Neo System |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $309.28 | 2019-2024 | Biomonitor |
| Bardy Diagnostics, INC. | $279.62 | 2019-2021 | |
| Inspire Medical Systems, INC. | $170.31 | 2024-2025 | Inspire |
| Astellas Pharma US INC | $145.68 | 2019 | |
| Novartis Pharmaceuticals Corporation | $143.30 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $135.26 | 2022-2025 | Farxiga, Andexxa, Brilinta |
| Janssen Pharmaceuticals, INC | $133.34 | 2019-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $124.55 | 2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.54 | 2022-2025 | Jardiance |
| Abiomed | $88.06 | 2019 | |
| Amgen INC. | $84.83 | 2019-2023 | Repatha |
| Sanofi-Aventis U.S. LLC | $83.65 | 2022-2023 | |
| Medtronic Vascular, INC. | $67.12 | 2019 | |
| Altathera Pharmaceuticals LLC | $45.70 | 2021-2022 | |
| Itamar Medical INC | $42.29 | 2021-2024 | Watchpatone |
| Lundbeck LLC | $38.21 | 2019-2020 | |
| Atricure, INC. | $31.78 | 2020-2023 | |
| Cardiofocus, INC. | $23.80 | 2021 | |
| Arbor Pharmaceuticals, INC. | $23.14 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $19.70 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $19.14 | 2022 | |
| Philips North America LLC | $17.26 | 2023 | |
| Akcea Therapeutics, INC. | $17.08 | 2019 | |
| Endotronix, INC. | $16.08 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Stereotaxis INC | $15.17 | 2019 | |
| Teleflex LLC | $14.83 | 2024 | Guideliner |
| Infobionic, INC | $14.66 | 2024 | Mome Device |
| Preventice Services, LLC | $13.55 | 2021 | |
| Elutia, INC. | $7.42 | 2025 | Ecm Patch,Pouch |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.